ARCHIVES

Opdivo Study Shows 41 Percent One-Year Survival In Patients With at Least Two Past Therapies

This article is from The Cancer Letter archive.

Vol. 37 No. 11 | November 28, 2014

Download PDF Visit The Full Archive

Related Articles

Ohio State Schedules Workshop On CCOP

February 5, 1982

FDA Describes Meeting With NCI In “Limited” Memo

May 7, 1976

NCI RFA: Basic Biobehavioral Research

August 6, 1999

New Therapies For Genitourinary Cancers In Clinical Testing Presented At ASCO

July 25, 2003

No Interest Seen Yet In Specialized Centers For Environmental Carcinogenesis

September 26, 1975

Abstracts Of ‘Most Newsworthy’ Papers

June 10, 1977